Advertisement

Metformin attenuates increase of synaptic number in the rat spinal dorsal horn with painful diabetic neuropathy induced by type 2 diabetes: a stereological study

  • Jing-yan Lin
  • Yi-na He
  • Na Zhu
  • Bin Peng
Original Paper
  • 10 Downloads

Abstract

In our previous study, we have shown that number of synapses in the L5 segment of spinal dorsal horn increased significantly in a rat model of painful diabetic neuropathy (PDN) induced by high-dose of streptozotocin (an animal model of type 1 diabetes). The aims of this study were: (1) to determine whether high fat diet/low dose streptozotocin-diabetes, a rat model for type 2 diabetes, related PDN was also associated with this synaptic plasticity, (2) to reveal the range of this synaptic plasticity change occurred (in the whole length of spinal dorsal horn or only in the L5 lumbar segment of spinal dorsal horn) and (3) to discover whether treatment with metformin had effect on this synaptic plasticity. Male adult Sprague–Dawley rats were randomly allocated into the control group (n = 7), the PDN group (n = 6) and the PDN treated with metformin (PDN + M) group (n = 7), respectively. 28 days after medication, synaptic and neuronal numbers in the whole length of spinal dorsal horn or in 1 mm length of the L5 segment of spinal dorsal horn were estimated by the optical disector (a stereological technique). Compared to the control group and the PDN + M group, number of synapses in the L5 segment of spinal dorsal horn increased significantly in the PDN group (P < 0.05). There was no significant change between the control group and the PDN + M group in terms of the parameters in the L5 segment of the spinal dorsal horn (P > 0.05). Parameters of the whole length of spinal dorsal horn showed no significant changes (P > 0.05). Our results suggest that high fat diet/low dose streptozotocin diabetes related PDN is also associated with a numerical increase of synapses in the L5 segment of spinal dorsal horn but not in the whole length of spinal dorsal horn. Furthermore, the analgesic effect of metformin against PDN is related to its inhibition of numerical increase of synaptic number in the rat spinal dorsal horn.

Keywords

Diabetes mellitus Neuropathic pain Synaptic plasticity Stereology Optical disector Metformin 

Notes

Acknowledgements

We thank Guoyun Qin, Buming Wan, Shuai He and Mingyou Wang (undergraduates of North Sichuan Medical College) for their assistance in the lab work and animal care.

Funding

This research was supported by the Grant of the Education Department of Sichuan (No. 16ZA0238) and the Grant from Special Project of Municipal-school Cooperation (NSMC20170443).

References

  1. 1.
    Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM et al (1993) The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester diabetic neuropathy study. Neurology 43(4):817–824CrossRefPubMedCentralGoogle Scholar
  2. 2.
    Schreiber AK, Nones CF, Reis RC, Chichorro JG, Cunha JM (2015) Diabetic neuropathic pain: physiopathology and treatment. World J Diabetes 6(3):432–444CrossRefPubMedCentralGoogle Scholar
  3. 3.
    Peltier A, Goutman SA, Callaghan BC (2014) Painful diabetic neuropathy. BMJ 348:g1799CrossRefGoogle Scholar
  4. 4.
    Bastyr EJ 3rd, Price KL, Bril V, MBBQ Study Group (2005) Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Clin Ther 27(8):1278–1294CrossRefPubMedCentralGoogle Scholar
  5. 5.
    Zieglar D, Gries FA, Spüler M, Lessmann F (1992) The epidemiology of diabetic neuropathy. Diabetic cardiovascular autonomic neuropathy multicenter study group. J Diabetes Complicat 6(1):49–57CrossRefGoogle Scholar
  6. 6.
    Fuchs D, Birklein F, Reeh PW, Sauser SK (2010) Sensitized peripheral nociception in experimental diabetes of the rat. Pain 151(2):496–505CrossRefPubMedCentralGoogle Scholar
  7. 7.
    Lin J-Y, Huang X-L, Chen J, Yang Z-W, Lin J, Huang S, Peng B (2017) Stereological study on the number of synapses in the rat spinal dorsal horn with painful diabetic neuropathy induced by streptozotocin. Neuroreport 28(6):319–324CrossRefPubMedCentralGoogle Scholar
  8. 8.
    Callaghan BC, Little AA, Feldman EL, Hughes RA (2012) Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev 13(6):CD007543Google Scholar
  9. 9.
    Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M (1995) Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 333(2):89–94CrossRefPubMedCentralGoogle Scholar
  10. 10.
    Mao-Ying QL, Kavelaars A, Krukowski K et al (2014) The anti-diabetic drug metformin protects against chemotherapy-induced peripheral neuropathy in a mouse model. PLoS ONE 9(6):e100701CrossRefPubMedCentralGoogle Scholar
  11. 11.
    Ma J, Yu H, Liu J et al (2015) Metformin attenuates hyperalgesia and allodynia in rats with painful diabetic neuropathy induced by streptozotocin. Eur J Pharmacol 764:599–606CrossRefPubMedCentralGoogle Scholar
  12. 12.
    Taylor A, Westveld AH, Szkudlinska M et al (2013) The use of metformin is associated with decreased lumbar radiculopathy pain. J Pain Res 6:755–763PubMedPubMedCentralGoogle Scholar
  13. 13.
    Russe OQ, Möser CV, Kynast KL et al (2013) Activation of the AMP-activated protein kinase reduces inflammatory nociception. J Pain 14(11):1330–1340CrossRefPubMedCentralGoogle Scholar
  14. 14.
    Łabuzek K, Liber S, Suchy D, Okopień B (2013) A successful case of pain management using metformin in a patient with adiposis dolorosa. Int J Clin Pharmacol Ther 51(6):517–524PubMedPubMedCentralGoogle Scholar
  15. 15.
    Zuo ZF, Wang W, Niu L et al (2011) RU486 (mifepristone) ameliorates cognitive dysfunction and reverses the down-regulation of astrocytic N-myc downstream-regulated gene2 in streptozotocin-induced type-1 diabetic rats. Neuroscience 190:156–165CrossRefPubMedCentralGoogle Scholar
  16. 16.
    Kou ZZ, Li CY, Tang J et al (2013) Down-regulation of insulin signaling is involved in painful diabetic neuropathy in type 2 diabetes. Pain Physician 16(2):E71–E83PubMedPubMedCentralGoogle Scholar
  17. 17.
    Chen SR, Pan HL (2002) Hypersensitivity of spinothalamic tract neurons associated with diabetic neuropathic pain in rats. J Neurophysiol 87(6):2726–2733CrossRefPubMedCentralGoogle Scholar
  18. 18.
    Mei XP, Zhou Y, Wang W et al (2011) Ketamine depresses toll-like receptor 3 signaling in spinal microglia in a rat model of neuropathic pain. Neurosignals 19(1):44–53CrossRefPubMedCentralGoogle Scholar
  19. 19.
    Chaplan SR, Bach FW, Pogrel JW et al (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53(1):55–63CrossRefPubMedCentralGoogle Scholar
  20. 20.
    Peng B, Lin JY, Shang Y et al (2010) Plasticity in the synaptic number associated with neuropathic pain in the rat spinal dorsal horn: a stereological study. Neurosci Lett 486(1):24–28CrossRefPubMedCentralGoogle Scholar
  21. 21.
    Morrow TJ (2004) Animal models of painful diabetic neuropathy: the STZ rat model. Curr Protoc Neurosci.  https://doi.org/10.1002/0471142301.ns0918s29. (Chap. 9:Unit 9.18).CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Gheibi S, Kashfi K, Ghasemi A (2017) A practical guide for induction of type-2 diabetes in rat: incorporating a high-fat diet and streptozotocin. Biomed Pharmacother 95:605–613.  https://doi.org/10.1016/j.biopha.2017.08.098 CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Lin JY, Peng B, Yang ZW, Min S (2011) Number of synapses increased in the rat spinal dorsal horn after sciatic nerve transection: a stereological study. Brain Res Bull 84(6):430–433CrossRefPubMedCentralGoogle Scholar
  24. 24.
    Zhou X, Wu LF (2003) Spinal cord. In: Cheng LZ, Zhong CP, Cai WQ (eds) Contemporary histology. Shanghai Scientific and Technological Literature Publishing House, Shanghai, pp 425–427 (book in Chinese) Google Scholar
  25. 25.
    Gundersen HJ, Bagger P, Bendtsen TF et al (1988) The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96(10):857–881CrossRefPubMedCentralGoogle Scholar
  26. 26.
    Martin MM (1953) Diabetic neuropathy; a clinical study of 150 cases. Brain 76(4):594–624CrossRefPubMedCentralGoogle Scholar
  27. 27.
    Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P et al (2010) Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33(10):2285–2293CrossRefPubMedCentralGoogle Scholar
  28. 28.
    Holland NR, Crawford TO, Hauer P, Cornblath DR, Griffin JW, McArthur JC (1998) Smallfiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol 44(1):47–59CrossRefPubMedCentralGoogle Scholar
  29. 29.
    Shehab SA (2009) Acute and chronic sectioning of fifth lumbar spinal nerve has equivalent effects on the primary afferents of sciatic nerve in rat spinal cord. J Comp Neurol 517(4):481–492CrossRefPubMedCentralGoogle Scholar
  30. 30.
    Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ (2011) Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the UK. Diabetes Care 34(10):2220–2224CrossRefPubMedCentralGoogle Scholar
  31. 31.
    The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329(14):977–986CrossRefGoogle Scholar
  32. 32.
    Linn T, Ortac K, Laube H, Federlin K (1996) Intensive therapy in adult insulin dependent diabetes mellitus is associated with improved insulin sensitivity and reserve: a randomized, controlled, prospective study over 5 years in newly diagnosed patients. Metabolism 45(12):1508–1513CrossRefPubMedCentralGoogle Scholar
  33. 33.
    Azad N, Emanuele NV, Abraira C, Henderson WG, Colwell J, Levin SR et al (1999) The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM). J Diabetes Complicat 13(5–6):307–313CrossRefPubMedCentralGoogle Scholar
  34. 34.
    Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD et al (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360(2):129–139CrossRefPubMedCentralGoogle Scholar
  35. 35.
    Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM et al (2010) Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 376(9739):419–430CrossRefPubMedCentralGoogle Scholar
  36. 36.
    Tovi J, Svanborg E, Nilsson BY, Engfeldt P (1998) Diabetic neuropathy in elderly type 2 diabetic patients: effects of insulin treatment. Acta Neurol Scand 98(5):346–353CrossRefPubMedCentralGoogle Scholar
  37. 37.
    Melemedjian OK, Khoutorsky A, Sorge RE, Yan J, Asiedu MN et al (2013) mTORC1 inhibition induces pain via IRS-1-dependent feedback activation of ERK. Pain 154(7):1080–1091CrossRefPubMedCentralGoogle Scholar
  38. 38.
    Melemedjian OK, Yassine HN, Shy A, Price TJ (2013) Proteomic and functional annotation analysis of injured peripheral nerves reveals ApoE as a protein upregulated by injury that is modulated by metformin treatment. Mol Pain 9:14PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of AnesthesiologyThe Affiliated Hospital of North Sichuan Medical CollegeNanchongChina
  2. 2.Department of AnesthesiologyNanchong Central HospitalNanchongChina
  3. 3.Research Unit of Electron Microscopy StructuresNorth Sichuan Medical CollegeNanchongChina

Personalised recommendations